Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Melissa H.S. Roeffen"'
Autor:
Winette T.A. van der Graaf, Otto C. Boerman, Wim J.G. Oyen, Peter J. Houghton, Hanneke W.M. van Laarhoven, Melissa H.S. Roeffen, Sandra Heskamp, Janneke D.M. Molkenboer-Kuenen, Addy C.M. van de Luijtgaarden, Yvonne M.H. Versleijen-Jonkers, Emmy D.G. Fleuren
Purpose: To investigate whether indium-111–labeled R1507 (111In-R1507) immuno-SPECT (single—photon emission computed tomography), a novel noninvasive, in vivo screening method to visualize membranous insulin-like growth factor 1 receptor (IGF-1R)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e726d33c6025a0dd031b2332df37e72
https://doi.org/10.1158/1078-0432.c.6520857
https://doi.org/10.1158/1078-0432.c.6520857
Autor:
Winette T.A. van der Graaf, Otto C. Boerman, Wim J.G. Oyen, Peter J. Houghton, Hanneke W.M. van Laarhoven, Melissa H.S. Roeffen, Sandra Heskamp, Janneke D.M. Molkenboer-Kuenen, Addy C.M. van de Luijtgaarden, Yvonne M.H. Versleijen-Jonkers, Emmy D.G. Fleuren
PDF file - 2.8MB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35320aa43a5df25ae0892e3c9e5ae293
https://doi.org/10.1158/1078-0432.22446741
https://doi.org/10.1158/1078-0432.22446741
Autor:
Uta Flucke, Wim J.G. Oyen, Winette T. A. van der Graaf, Melissa H.S. Roeffen, Emmy D.G. Fleuren, Peter J. Houghton, Gerben M. Franssen, Yvonne M.H. Versleijen-Jonkers, Otto C. Boerman
Publikováno v:
International Journal of Cancer. 135:2770-2782
Mammalian target of rapamycin (mTOR) is a new promising oncological target. However, most clinical studies reported only modest antitumor activity during mTOR-targeted monotherapies, including studies in osteosarcomas, emphasizing a need for improvem
Autor:
Myrella Vlenterie, Winette T. A. van der Graaf, Emmy D.G. Fleuren, Otto C. Boerman, Yvonne M.H. Versleijen-Jonkers, William P.J. Leenders, Melissa H.S. Roeffen, Uta Flucke, Hendrik W. Schreuder
Publikováno v:
International Journal of Cancer. 133:427-436
Because novel therapeutic options are limited in Ewing sarcomas (ES), we investigated the expression, genetic aberrations and clinical relevance of MET and anaplastic lymphoma kinase (ALK) in ES and determined the relevance of targeting these recepto
Autor:
Paul N. Span, Yvonne M.H. Versleijen-Jonkers, Hanneke W. M. van Laarhoven, Ger J. M. Pruijn, Melissa H.S. Roeffen, Fred C.G.J. Sweep, Chantal van de Schootbrugge, Johannes H.A.M. Kaanders, Johan Bussink, Wilbert C. Boelens, Freekje van Asten, Iris D. Nagtegaal
Publikováno v:
International Journal of Biological Markers, 28, e365-70
International Journal of Biological Markers, 28, 4, pp. e365-70
International journal of biological markers, 28(4), e365-e370. Wichtig Publishing
International Journal of Biological Markers, 28, 4, pp. e365-70
International journal of biological markers, 28(4), e365-e370. Wichtig Publishing
Contains fulltext : 125273pub.pdf (Publisher’s version ) (Closed access) alphaB-crystallin is regarded as a biomarker for triple-negative and/or basal-like breast cancer. In normal breast cells, overexpression of alphaB-crystallin leads to neoplast
Autor:
Jeroen van der Laak, Winette T. A. van der Graaf, J. Carlijn van Gaal, Gwen van der Heijden, Albert J. H. Suurmeijer, Uta Flucke, Eveline S. J. M. de Bont, Yvonne M.H. Versleijen-Jonkers, Melissa H.S. Roeffen
Publikováno v:
European Journal of Cancer, 49, 3462-70
European Journal of Cancer, 49, 16, pp. 3462-70
European Journal of Cancer, 49(16), 3462-3470. ELSEVIER SCI LTD
European Journal of Cancer, 49, 16, pp. 3462-70
European Journal of Cancer, 49(16), 3462-3470. ELSEVIER SCI LTD
Contains fulltext : 126252.pdf (Publisher’s version ) (Open Access) BACKGROUND: Rhabdomyosarcoma (RMS) is an aggressive soft tissue tumour mainly affecting children and adolescents. Since survival of high-risk patients remains poor, new treatment o
Autor:
Winette T. A. van der Graaf, Eveline S. J. M. de Bont, Albert J. H. Suurmeijer, Melissa H.S. Roeffen, Yvonne M.H. Versleijen-Jonkers, Annelies M. C. Mavinkurve-Groothuis, J. Carlijn van Gaal, Uta Flucke, Stefan Sleijfer
Publikováno v:
Journal of Clinical Oncology, 30(3), 308-315. American Society of Clinical Oncology
Journal of Clinical Oncology, 30, 3, pp. 308-15
Journal of Clinical Oncology, 30, 308-15
Journal of Clinical Oncology, 30(3), 308-315. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 30, 3, pp. 308-15
Journal of Clinical Oncology, 30, 308-15
Journal of Clinical Oncology, 30(3), 308-315. AMER SOC CLINICAL ONCOLOGY
Purpose The aim of this study is to investigate anaplastic lymphoma kinase (ALK) protein expression and underlying genetic aberrations in rhabdomyosarcoma (RMS), with special attention to clinical and prognostic implications. Patients and Methods A t
Autor:
Uta Flucke, Yvonne M.H. Versleijen-Jonkers, H.W.B. Schreuder, W.T.A. van der Graaf, A.C.M. van de Luijtgaarden, Melissa H.S. Roeffen
Publikováno v:
Targeted Oncology, 8, 253-60
Targeted Oncology, 8, 4, pp. 253-60
Targeted Oncology, 8, 4, pp. 253-60
Contains fulltext : 125804.pdf (Publisher’s version ) (Closed access) The optimal target and timing of drugs interfering with the insulin-like growth factor (IGF) signaling system in Ewing's sarcoma (ES) remain undetermined. We examined the express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c4c1d33bea1e7993e13c86d0940f1d
http://hdl.handle.net/2066/125804
http://hdl.handle.net/2066/125804
Autor:
Melissa H.S. Roeffen, Hanneke W. M. van Laarhoven, Winette T. A. van der Graaf, Sandra Heskamp, Yvonne M.H. Versleijen-Jonkers, Otto C. Boerman, Wim J.G. Oyen, Emmy D.G. Fleuren, Wilbert H. Bouwman, Janneke D.M. Molkenboer-Kuenen
Publikováno v:
European Journal of Cancer, 49, 13, pp. 2851-8
European Journal of Cancer, 49, 2851-8
European journal of cancer (Oxford, England, 49(13), 2851-2858. Elsevier Limited
European Journal of Cancer, 49, 2851-8
European journal of cancer (Oxford, England, 49(13), 2851-2858. Elsevier Limited
Item does not contain fulltext PURPOSE: To investigate whether F(ab')2-fragments of the monoclonal Insulin-like Growth Factor-1 Receptor (IGF-1R) antibody R1507 (F(ab')2-R1507) can successfully target IGF-1R in Ewing sarcomas (ES). MATERIALS AND METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16cd3f3077b6aa8db00998a36b53443
https://doi.org/10.1016/j.ejca.2013.04.009
https://doi.org/10.1016/j.ejca.2013.04.009
Autor:
Uta Flucke, Bart Schreuder, Manon A Leus, Yvonne M.H. Versleijen-Jonkers, Addy C.M. van de Luijtgaarden, Melissa H.S. Roeffen, Winette T. A. van der Graaf
Publikováno v:
Future Oncology, 9, 11, pp. 1733-40
Future Oncology, 9, 1733-40
Future Oncology, 9, 1733-40
Aim: The aim of this study was to examine the expression of the IGF signaling pathway components in osteosarcoma samples before and after chemotherapy with special emphasis on their prognostic value. Materials & methods: Tumor material and follow-up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b060eace79805d8e3c12a57642acc5a7
https://hdl.handle.net/2066/125839
https://hdl.handle.net/2066/125839